PVI
RCEL icon

Pura Vida Investments’s Avita Medical RCEL Stock Holding History

Pura Vida Investments’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,000
Closed -$561K – 65
2024
Q1 		$561K Sell
35,000
-326,096
-90% -$5.28M 0.09% 48
2023
Q4 		$4.95M Sell
361,096
-119,547
-25% -$1.37M 0.76% 20
2023
Q3 		$7.02M Buy
480,643
+54,322
+13% +$919K 1.33% 28
2023
Q2 		$7.25M Sell
426,321
-372,601
-47% -$5.47M 0.96% 31
2023
Q1 		$11.2M Sell
798,922
-135,311
-14% -$1.44M 1.13% 29
2022
Q4 		$6.17M Buy
934,233
+75,282
+9% +$451K 0.32% 76
2022
Q3 		$4.53M Buy
858,951
+117,076
+16% +$723K 0.26% 93
2022
Q2 		$3.52M Buy
741,875
+67,559
+10% +$417K 0.2% 109
2022
Q1 		$5.72M Buy
+674,316
New +$6.21M 0.19% 114
2021
Q4 		– Sell
-252,246
Closed -$4.47M – 296
2021
Q3 		$4.47M Sell
252,246
-6,705
-3% -$127K 0.14% 151
2021
Q2 		$5.31M Sell
258,951
-124,638
-32% -$2.46M 0.17% 111
2021
Q1 		$7.6M Buy
+383,589
New +$8.92M 0.22% 97

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pura Vida Investments's RCEL Position: Q2 2024 in Review

Pura Vida Investments sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 35,000 shares — an estimated $561K sold.

Pura Vida Investments first reported a position in RCEL in Q1 2021 and held it in 12 quarters. The position peaked at $11.2M in Q1 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Pura Vida Investments reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 35,000 Avita Medical shares in Q2 2024, an estimated $561K.
  • Pura Vida Investments first reported a position in Avita Medical in Q1 2021 and held it in 12 quarters.
  • Pura Vida Investments's Avita Medical position peaked at $11.2M in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.